Endocrine Journal
Online ISSN : 1348-4540
Print ISSN : 0918-8959
ISSN-L : 0918-8959
High circulating follistatin-like protein 1 as a biomarker of a metabolically unhealthy state
Sun-Young LeeDeog-Yoon KimMi Kyung KwakSeong Hee AhnHyeonmok KimBeom‑Jun KimJung-Min KohYumie RheeChong Hwa KimKi Hyun BaekYong-Ki MinSeung Hun LeeMoo-Il Kang
ジャーナル フリー 早期公開

論文ID: EJ18-0352


The inflammatory biomarkers that fully characterize the metabolically unhealthy (MU) state—which is a risk factor for cardiovascular disease (CVD)—remain unclear. Recent studies suggest follistatin-like protein 1 (FSTL1) could be used as a biomarker for inflammation and CVD, however there is little information on FSTL1 levels in the MU state. We aimed to evaluate the associations between FSTL1, the presence of MU state and subclinical coronary atherosclerosis. In a cross-sectional study, we evaluated FSTL1 levels and their relationship with the presence of MU state and coronary artery plaques in 230 Korean patients. Significant increase in FSTL1 levels was observed in subjects with MU state (p = 0.020), but not those with obesity state according to body mass index criteria (p = 0.790). After adjusting for confounders, the odd ratio (OR) for the MU state among patients in the highest FSTL1 tertile (T3) was higher in comparison with the lowest tertile (T1) (OR = 3.60, 95% confidence interval [95% CI] = 1.20–10.83). In a subgroup (n = 66), FSTL1 levels were also marginally higher in patients with plaques (p = 0.098). The OR for plaque presence in patients with T3 was significantly higher in comparison with T1 after adjusting for confounders (OR = 12.51, 95% CI = 1.15–135.73). Plasma FSTL1 may be a useful biomarker for the risk of MU state and CVD.

© The Japan Endocrine Society